Obesity Trial, Recruiting NCT05242835 Sponsor: Laval University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT05242835
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who had a sleeve gastrectomy (a type of weight-loss stomach surgery) at least 18 months ago.
  • People whose body weight still meets the standard guidelines for weight-loss surgery — either a BMI of 35 or above with serious weight-related health conditions, or a BMI of 40 or above — OR people who lost less than 50% of their excess weight after surgery, or who have regained a significant amount of weight (at least 20% of the excess weight they originally lost).

Who may not be able to join:

  • People who have a general medical reason that would make weight-loss surgery unsafe for them.
  • People with a BMI below 35.
  • People who are pregnant.
  • People who have cirrhosis (serious scarring of the liver).
  • People who have ongoing bowel problems, including irritable bowel syndrome (IBS) or inflammatory bowel disease (such as Crohn's disease or ulcerative colitis).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Laurent Biertho, MD, Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Phone: 418-656-8711

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Laval University
Registry
ClinicalTrials.gov
Start date
3 February 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Excess weight loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov